Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Eiger BioPharmaceuticals, Inc

+1 (650) 272-6138

Advertisement

Advertisement

2155 Park Blvd
Palo Alto, CA 94306
+1 (650) 272-6138

Eiger Biopharmaceuticals is a research-driven biopharmaceutical company based in Palo Alto, CA. The company focuses on developing innovative therapies for serious diseases with unmet medical needs.

Utilizing cutting-edge technology and scientific expertise, Eiger Biopharmaceuticals is dedicated to advancing novel treatments to improve patient outcomes and quality of life.

Generated from their business information

Also at this address

EB Pharma, LLC

Universal Building System

Intrepid Technology Inc

Find related places

Pharmacy

Pharmacy

Own this business?
Claim it
See a problem?

You might also like

Titan Pharmaceuticals, Inc
Business management consultant, Blood derivatives, Drugs and drug proprietaries

Titan Pharmaceuticals, Inc

Titan Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes partnerships with government institutions and other leading pharmaceutical development companies. Titan Pharmaceuticals is headquartered in San Francisco.
Avg Technologies
Business services, nec, nec, Custom computer programming services, Art gallery

Avg Technologies

Dynavax Technologies Corporation was founded in August 1996. The company discovers, develops and intends to commercialize products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, using proprietary approaches that alter immune system responses in specific ways. Its clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Dynavax s pipeline includes: TOLAMBA, a ragweed allergy immunotherapeutic, which has completed a large-scale Phase 2/3 clinical trial, and is in a supportive clinical trial in ragweed allergic children; HEPLISAV, a hepatitis B vaccine that is in a pivotal Phase 3 clinical trial; a cancer therapy in a Phase 2 clinical trial; and an asthma immunotherapeutic that has shown preliminary safety and pharmacologic activity in a Phase 2a clinical trial.
Drugs and drug proprietaries, Vitamin, nutrient, and hematinic preparations for human use

Corvus Pharmaceuticals, Inc

Corvus Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Burlingame, CA, dedicated to developing innovative medicines for cancer and immune diseases. With a strong focus on ITK (interleukin-2-inducible T-cell kinase) inhibition, their platform opportunity holds great promise for improving the lives of patients. Driven by a passion for scientific advancement, Corvus Pharmaceuticals is led by a team of experienced professionals who are committed to pushing the boundaries of medical research. Through their cutting-edge approach and robust pipeline, the company aims to make significant contributions to the field of oncology and immunology.Generated from the website
United States›California›Palo Alto›Eiger BioPharmaceuticals, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell